Treatment-Resistant Mood Disorders

by André F Carvalho (Editor), Roger S McIntyre (Editor)

Overview

Treatment-resistant major depression and bipolar disorder are highly prevalent and disabling conditions associated with substantial morbidity and mortality. The assessment and management of refractory patients with mood disorders is a major clinical challenge for mental health providers. Part of the Oxford Psychiatry Library (OPL) series, this pocketbook provides a concise view of the current definitions, assessment and evidence-based management of treatment-resistant mood disorders and reviews novel therapeutic targets for mood disorders, which may enhance the therapeutic armamentarium of clinicians in the near future. The pocketbook serves as a useful guide for mental health practitioners, including psychiatrists, clinical psychologists, trainees, and interested primary care physicians.

Product Details

ISBN-13:	9780191017841
Publisher:	OUP Oxford
Publication date:	03/26/2015
Series:	Oxford Psychiatry Library
Sold by:	Barnes & Noble
Format:	eBook
Pages:	160
File size:	4 MB

About the Author

Professor André F. Carvalho, MD, PhD, Associate Professor of Psychiatry, Psychiatry Research Group, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE Brazil. Roger S. McIntyre is currently a Professor of Psychiatry and Pharmacology at the University of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto, Canada. He was named by Thomson Reuters in 2014 as one of "The World's Most Influential Scientific Minds" for publishing the largest number of articles that rank among those most frequently cited by researchers globally during the previous decade. Dr. McIntyre is involved in multiple research endeavours which primarily aim to characterize the association between mood disorders, notably cognitive function and medical comorbidity. This body of work has provided a platform for identifying novel molecular targets to treat and prevent mood disorders and accompanying cognitive impairment.

Table of Contents

1. Treatment-resistant major depressive disorder: Current Definitions, Epidemiology and Assessment, Marcelo T. Berlim, Santiago Tovar-Perdomo and Marcelo P. A. Fleck
2. Treatment-resistant bipolar disorder: current definitions, epidemiology and assessment, Chris Abbott and Mauricio Tohen
3. Determinants of Treatment Resistance: Health Systems and Public Policy Implications, Jelena Vrublevska and Konstantinos N. Fountoulakis
4. The influence of psychiatric and medical comorbidities in treatment resistance for mood disorders, Sheng-Min Wang and Chi-Un Pae
5. Predictors of treatment response in major depressive disorder, Andrew Haddon Kemp, Andre Russowsky Brunoni and Rodrigo Machado-Vieira
6. Predictors of Treatment Response in Bipolar Disorder: Lessons from Longitudinal Studies, Benicio N. Frey
7. Evidence-based Pharmacological Approaches for Treatment-Resistant Major Depressive Disorder, Andre F. Carvalho, Thomas N. Hyphantis and Roger S. McIntyre
8. Evidence-based pharmacological approaches for treatment-resistant bipolar disorder, Poon SH and Sim K
9. Psychosocial management of treatment-resistant mood disorders: current evidence, Jenny Guidi and Giovanni A. Fava
10. Electroconvulsive therapy for treatment-resistant mood disorders, Eric Cretaz, Alexandre Duarte Gigante and Beny Lafer
11. Novel non-invasive brain stimulation approaches for treatment-resistant mood disorders, Andre Russowsky Brunoni, Pedro Shiozawa and Felipe Fregni
12. Vagus Nerve Stimulation and Deep Brain Stimulation: Implantable Device-Related Neurostimulation for Treatment-Resistant Mood Disorders, Giacobbe P, Lipsman N, Lozano A and Kennedy SH
13. Novel Therapeutic Targets for Major Depressive Disorder, Marcio Gerhardt Soeiro-de-Souza and Rodrigo Machado-Vieira
14. Novel therapeutic targets for bipolar disorder, Seetal Dodd